Ironwood Pharmaceuticals (IRWD)
Create an Alert
12.19
-0.24 -1.93%
NASDAQ
Jun 19, 11:57AM
BATS Real time
Currency in USD
Ironwood Pharmaceuticals Net Income Quarterly:
-93.90M for March 31, 2013Ironwood Pharmaceuticals Historical Net Income Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -93.90M |
| Dec. 31, 2012 | -43.86M |
| Sept. 30, 2012 | 47.64M |
| June 30, 2012 | -40.80M |
| March 31, 2012 | -35.60M |
| Dec. 31, 2011 | -6.974M |
| Sept. 30, 2011 | -20.63M |
| June 30, 2011 | -18.84M |
| March 31, 2011 | -18.40M |
| Dec. 31, 2010 | -11.65M |
| Sept. 30, 2010 | -8.27M |
| June 30, 2010 | -17.14M |
| March 31, 2010 | -15.92M |
| Dec. 31, 2009 | -23.93M |
| Sept. 30, 2009 | -10.90M |
| June 30, 2009 | -18.38M |
| March 31, 2009 | -17.97M |
| Dec. 31, 2008 | -11.23M |
About Net Income
Net income is what remains of a company's revenue after subtracting all costs. It is also referred to as net profit, earnings, or the bottom line. Net Income that is not paid out in dividends is added to retained earnings.
Increasing (decreasing) net income is a good (bad) sign for a company's profitability. Companies with consistent and increasing net income over time are looked at very favorably by stockholders.
Learn More
IRWD Net Income Quarterly Benchmarks
| Companies | |
|---|---|
| Synergy Pharmaceuticals | -11.98M |
| Parexel International Corporation | 29.52M |
| Icon | 19.04M |
IRWD Net Income Quarterly Rankings
| Overall |
41st percentile 9744 of 16782 |
| Sector |
28th percentile 1013 of 1410 in Healthcare |
| Industry |
24th percentile 98 of 130 in Diagnostics & Research |
IRWD Net Income Quarterly Range, Past 5 Years
| Minimum | -93.90M | Mar 2013 |
| Maximum | 47.63M | Sep 2012 |
| Average | -20.38M |
